Enfusion Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Operating Revenue	200.21	173.29	148.69	110.38	77.99
Other Revenue	1.4	1.24	1.66	1.32	1.58
Revenue	201.61	174.54	150.35	111.7	79.57
Revenue Growth (YoY)	15.51%	16.09%	34.60%	40.39%	34.79%
Cost of Revenue	64.87	57.64	47.1	31.85	21.36
Gross Profit	136.74	116.89	103.25	79.86	58.21
Selling, General & Admin	103.86	85.05	98.05	202.34	45.82
Research & Development	26.73	19.89	17.16	153.4	6.32
Operating Expenses	130.58	104.95	115.21	355.74	52.13
Operating Income	6.16	11.95	-11.96	-275.88	6.07
Interest Expense	-	-	-	-4.59	-1.66
Interest & Investment Income	1.69	1.64	0.41	-	-
Other Non Operating Income (Expenses)	-0.46	-2.11	-0.64	-1.19	0.08
Pretax Income	7.39	11.48	-12.19	-281.66	4.49
Income Tax Expense	3.47	2.23	1.07	0.58	0.43
Earnings From Continuing Operations	3.92	9.25	-13.26	-282.24	4.06
Minority Interest in Earnings	-1.09	-3.23	5.61	123.93	-
Net Income	2.82	6.03	-7.65	-158.32	4.06
Preferred Dividends & Other Adjustments	-	-0.31	0.95	29.47	-
Net Income to Common	2.82	6.33	-8.61	-187.79	4.06
Net Income Growth	-53.14%	-	-	-	-67.91%
Shares Outstanding (Basic)	92	88	85	83	0
Shares Outstanding (Diluted)	130	129	85	83	0
Shares Change (YoY)	0.09%	51.57%	2.83%	173025.83%	-
EPS (Basic)	0.03	0.07	-0.10	-2.26	84.66
EPS (Diluted)	0.03	0.07	-0.10	-2.26	84.66
EPS Growth	-57.73%	-	-	-	-
Free Cash Flow	31.05	21.18	10.17	-6.41	-3.4
Free Cash Flow Per Share	0.24	0.16	0.12	-0.08	-70.94
Gross Margin	67.82%	66.97%	68.67%	71.49%	73.16%
Operating Margin	3.05%	6.85%	-7.96%	-246.99%	7.63%
Profit Margin	1.40%	3.63%	-5.73%	-168.12%	5.10%
Free Cash Flow Margin	15.40%	12.14%	6.77%	-5.74%	-4.28%
EBITDA	12.71	18.54	-7.82	-273.21	7.61
EBITDA Margin	6.30%	10.62%	-5.20%	-244.59%	9.56%
D&A For EBITDA	6.55	6.59	4.14	2.68	1.53
EBIT	6.16	11.95	-11.96	-275.88	6.07
EBIT Margin	3.05%	6.85%	-7.96%	-246.99%	7.63%
Effective Tax Rate	47.02%	19.43%	-	-	9.63%
Revenue as Reported	201.61	174.54	150.35	111.7	79.57
Advertising Expenses	1.8	1.5	1.5	1.2	1.3

Updated Mar 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q